Literature DB >> 23962428

Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis.

Jian Wang1, Jingwu Li, Xiuchao Wang, Chen Zheng, Weidong Ma.   

Abstract

miR-214 is one of the most significantly downregulated microRNAs (miRNAs) in hepatocellular carcinoma (HCC). Fibroblast growth factor receptor 1 (FGFR-1) is a miR-214 target gene implicated in the progression of HCC. However, the roles of miR-214 and FGFR-1 in HCC are not fully understood. Here, we analyzed the expression of miR-214 and FGFR-1 in 65 cases of HCC and paired non-neoplastic tissue specimens using real-time PCR and Western blot (WB), respectively. Our data indicated that miR-214 was downregulated and FGFR-1 was overexpressed in HCC compared to the paired non-neoplastic tissues. The low miR-214 expression was correlated with portal vein invasion (p=0.016) and early recurrence (p=0.045) in HCC patients. Moreover, the low miR-214 expression was correlated with high positive rate of FGFR-1 in HCC cases (p=0.020). Our data further demonstrated that miR-214 overexpression in SK-HEP1 and HepG2 cells downregulated FGFR-1 expression and inhibited liver cancer cell invasion. The Luciferase assay results further demonstrated the targeted regulation of FGFR-1 by miR-214. In conclusion, our data indicate that the downregulation of miR-214 in HCC and the upregulation of its target gene FGFR-1 is associated with HCC progression. Therefore, miR-214 and FGFR-1 are potential prognostic markers and therapeutic targets in HCC.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGFR-1; Hepatocellular carcinoma; Metastasis; miR-214

Mesh:

Substances:

Year:  2013        PMID: 23962428     DOI: 10.1016/j.bbrc.2013.08.032

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  (125)I-labeled anti-bFGF monoclonal antibody inhibits growth of hepatocellular carcinoma.

Authors:  Peng-Hui Hu; Lan-Hong Pan; Patrick Ting-Yat Wong; Wen-Hui Chen; Yan-Qing Yang; Hong Wang; Jun-Jian Xiang; Meng Xu
Journal:  World J Gastroenterol       Date:  2016-06-07       Impact factor: 5.742

2.  The Effect of miR-98 and miR-214 on Apoptotic and Angiogenic Pathways in Hepatocellular Carcinoma HepG2 Cells.

Authors:  Shaymaa M M Yahya; Shereen M M Yahya
Journal:  Indian J Clin Biochem       Date:  2019-03-11

3.  Persistent changes in liver methylation and microbiome composition following reversal of diet-induced non-alcoholic-fatty liver disease.

Authors:  Hyejin Kim; Oliver Worsley; Edwin Yang; Rikky Wenang Purbojati; Ai Leng Liang; Wilson Tan; Daniela I Drautz Moses; Septian Hartono; Vanessa Fan; Tony Kiat Hon Lim; Stephan C Schuster; Roger Sy Foo; Pierce Kah Hoe Chow; Sven Pettersson
Journal:  Cell Mol Life Sci       Date:  2019-05-22       Impact factor: 9.261

Review 4.  Roles of FGFR in oral carcinogenesis.

Authors:  Xiaoyan Xie; Zhiyong Wang; Fangman Chen; Yao Yuan; Jiayi Wang; Rui Liu; Qianming Chen
Journal:  Cell Prolif       Date:  2016-06       Impact factor: 6.831

5.  Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma.

Authors:  Kirthana Prabhakar; Carlos I Rodrίguez; Ashika S Jayanthy; Dareen M Mikheil; Aishwarya Iyer Bhasker; Ranjan J Perera; Vijayasaradhi Setaluri
Journal:  Mol Carcinog       Date:  2019-07-24       Impact factor: 4.784

Review 6.  miR-214 as a key hub that controls cancer networks: small player, multiple functions.

Authors:  Elisa Penna; Francesca Orso; Daniela Taverna
Journal:  J Invest Dermatol       Date:  2014-12-11       Impact factor: 8.551

7.  Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.

Authors:  Shirong Zhang; Xiaodong Liang; Xiaoliang Zheng; Haixiu Huang; Xufeng Chen; Kan Wu; Bing Wang; Shenglin Ma
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

8.  Emerging roles of FGF signaling in hepatocellular carcinoma.

Authors:  Nana Zheng; Wenyi Wei; Zhiwei Wang
Journal:  Transl Cancer Res       Date:  2016-02       Impact factor: 1.241

9.  Combined aberrant expression of microRNA-214 and UBC9 is an independent unfavorable prognostic factor for patients with gliomas.

Authors:  Shuai Wang; Baohua Jiao; Shaomei Geng; Shucheng Ma; Zhaohui Liang; Shengkui Lu
Journal:  Med Oncol       Date:  2013-11-26       Impact factor: 3.064

Review 10.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.